BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 32480326)

  • 21. A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who Survived COVID-19 Disease: Case Presentation and Current Data of COVID-19 Infection in Dialysis and Transplanted Patients in Greece.
    Marinaki S; Tsiakas S; Skalioti C; Lourida P; Argyraki A; Grigorakos K; Boletis I
    Medicina (Kaunas); 2020 Jul; 56(7):. PubMed ID: 32708858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?
    Mégarbane B; Scherrmann JM
    J Clin Pharmacol; 2020 Jul; 60(7):808-814. PubMed ID: 32434282
    [No Abstract]   [Full Text] [Related]  

  • 23. Three Cases of COVID-19 Disease With Colonic Manifestations.
    Sattar Y; Connerney M; Rauf H; Saini M; Ullah W; Mamtani S; Syed U; Luddington S; Walfish A
    Am J Gastroenterol; 2020 Jun; 115(6):948-950. PubMed ID: 32427677
    [No Abstract]   [Full Text] [Related]  

  • 24. High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review : High levels of anti-SSA/Ro antibodies in COVID-19.
    Fujii H; Tsuji T; Yuba T; Tanaka S; Suga Y; Matsuyama A; Omura A; Shiotsu S; Takumi C; Ono S; Horiguchi M; Hiraoka N
    Clin Rheumatol; 2020 Nov; 39(11):3171-3175. PubMed ID: 32844364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CT Scan Findings of Five Mildly Symptomatic COVID Patients from India.
    Saseedharan S; Kadam V; Karanam R; Baghel P
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):48-49. PubMed ID: 32723450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
    Maisonnasse P; Guedj J; Contreras V; Behillil S; Solas C; Marlin R; Naninck T; Pizzorno A; Lemaitre J; Gonçalves A; Kahlaoui N; Terrier O; Fang RHT; Enouf V; Dereuddre-Bosquet N; Brisebarre A; Touret F; Chapon C; Hoen B; Lina B; Calatrava MR; van der Werf S; de Lamballerie X; Le Grand R
    Nature; 2020 Sep; 585(7826):584-587. PubMed ID: 32698191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 outcomes in MS: Observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center.
    Parrotta E; Kister I; Charvet L; Sammarco C; Saha V; Charlson RE; Howard J; Gutman JM; Gottesman M; Abou-Fayssal N; Wolintz R; Keilson M; Fernandez-Carbonell C; Krupp LB; Zhovtis Ryerson L
    Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32646885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 in multiple sclerosis: The Dutch experience.
    Loonstra FC; Hoitsma E; van Kempen ZL; Killestein J; Mostert JP
    Mult Scler; 2020 Sep; 26(10):1256-1260. PubMed ID: 32662742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of the initial patients hospitalized for COVID-19: a single-center report.
    Medetalibeyoğlu A; Şenkal N; Çapar G; Köse M; Tükek T
    Turk J Med Sci; 2020 Aug; 50(5):1436-1439. PubMed ID: 32490641
    [No Abstract]   [Full Text] [Related]  

  • 30. Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19).
    Bartiromo M; Borchi B; Botta A; Bagalà A; Lugli G; Tilli M; Cavallo A; Xhaferi B; Cutruzzulà R; Vaglio A; Bresci S; Larti A; Bartoloni A; Cirami C
    Transpl Infect Dis; 2020 Aug; 22(4):e13286. PubMed ID: 32279418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rhabdomyolysis as an initial presentation in a patient diagnosed with COVID-19.
    Valente-Acosta B; Moreno-Sanchez F; Fueyo-Rodriguez O; Palomar-Lever A
    BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32587121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy.
    Dinkin M; Gao V; Kahan J; Bobker S; Simonetto M; Wechsler P; Harpe J; Greer C; Mints G; Salama G; Tsiouris AJ; Leifer D
    Neurology; 2020 Aug; 95(5):221-223. PubMed ID: 32358218
    [No Abstract]   [Full Text] [Related]  

  • 33. Evolution and resolution of brain involvement associated with SARS- CoV2 infection: A close Clinical - Paraclinical follow up study of a case.
    Afshar H; Yassin Z; Kalantari S; Aloosh O; Lotfi T; Moghaddasi M; Sadeghipour A; Emamikhah M
    Mult Scler Relat Disord; 2020 Aug; 43():102216. PubMed ID: 32464585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eleven faces of coronavirus disease 2019.
    Dong X; Cao YY; Lu XX; Zhang JJ; Du H; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1699-1709. PubMed ID: 32196678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin.
    Anupama BK; Adhikari S; Chaudhuri D
    J Investig Med High Impact Case Rep; 2020; 8():2324709620948407. PubMed ID: 32762368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS
    Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod.
    Foerch C; Friedauer L; Bauer B; Wolf T; Adam EH
    Mult Scler Relat Disord; 2020 Jul; 42():102180. PubMed ID: 32408155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
    Sanders JM; Monogue ML; Jodlowski TZ; Cutrell JB
    JAMA; 2020 May; 323(18):1824-1836. PubMed ID: 32282022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab.
    Cai S; Sun W; Li M; Dong L
    Clin Rheumatol; 2020 Sep; 39(9):2797-2802. PubMed ID: 32562070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover.
    Soresina A; Moratto D; Chiarini M; Paolillo C; Baresi G; Focà E; Bezzi M; Baronio B; Giacomelli M; Badolato R
    Pediatr Allergy Immunol; 2020 Jul; 31(5):565-569. PubMed ID: 32319118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.